Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. [electronic resource]

By:

Younes, Anas

Contributor(s):

Gopal, Ajay K
Smith, Scott E
Ansell, Stephen M
Rosenblatt, Joseph D
Savage, Kerry J
Ramchandren, Radhakrishnan
Bartlett, Nancy L
Cheson, Bruce D
de Vos, Sven
Forero-Torres, Andres
Moskowitz, Craig H
Connors, Joseph M
Engert, Andreas
Larsen, Emily K
Kennedy, Dana A
Sievers, Eric L
Chen, Robert

Producer: 20120816Description: 2183-9 p. digitalISSN:

1527-7755

Subject(s):

Adolescent
Adult
Aged
Antineoplastic Agents -- therapeutic use
Brentuximab Vedotin
Disease-Free Survival
Female
Hodgkin Disease -- drug therapy
Humans
Immunoconjugates -- adverse effects
Male
Middle Aged
Recurrence
Young Adult

Online resources:

Available from publisher's website

In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

There are no comments on this title.

Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma.

APA

Younes A., Gopal A. K., Smith S. E., Ansell S. M., Rosenblatt J. D., Savage K. J., Ramchandren R., Bartlett N. L., Cheson B. D., de Vos S., Forero-Torres A., Moskowitz C. H., Connors J. M., Engert A., Larsen E. K., Kennedy D. A., Sievers E. L. & Chen R. (20120816). Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chicago

Younes Anas, Gopal Ajay K, Smith Scott E, Ansell Stephen M, Rosenblatt Joseph D, Savage Kerry J, Ramchandren Radhakrishnan, Bartlett Nancy L, Cheson Bruce D, de Vos Sven, Forero-Torres Andres, Moskowitz Craig H, Connors Joseph M, Engert Andreas, Larsen Emily K, Kennedy Dana A, Sievers Eric L and Chen Robert. 20120816. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Harvard

Younes A., Gopal A. K., Smith S. E., Ansell S. M., Rosenblatt J. D., Savage K. J., Ramchandren R., Bartlett N. L., Cheson B. D., de Vos S., Forero-Torres A., Moskowitz C. H., Connors J. M., Engert A., Larsen E. K., Kennedy D. A., Sievers E. L. and Chen R. (20120816). Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MLA

Younes Anas, Gopal Ajay K, Smith Scott E, Ansell Stephen M, Rosenblatt Joseph D, Savage Kerry J, Ramchandren Radhakrishnan, Bartlett Nancy L, Cheson Bruce D, de Vos Sven, Forero-Torres Andres, Moskowitz Craig H, Connors Joseph M, Engert Andreas, Larsen Emily K, Kennedy Dana A, Sievers Eric L and Chen Robert. Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin's lymphoma. : Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 20120816.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC